| Product NDC: | 0781-6270 |
| Proprietary Name: | Oxcarbazepine |
| Non Proprietary Name: | oxcarbazepine |
| Active Ingredient(s): | 60 mg/mL & nbsp; oxcarbazepine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-6270 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021285 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20010530 |
| Package NDC: | 0781-6270-43 |
| Package Description: | 250 mL in 1 BOTTLE (0781-6270-43) |
| NDC Code | 0781-6270-43 |
| Proprietary Name | Oxcarbazepine |
| Package Description | 250 mL in 1 BOTTLE (0781-6270-43) |
| Product NDC | 0781-6270 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxcarbazepine |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20010530 |
| Marketing Category Name | NDA |
| Labeler Name | Sandoz Inc |
| Substance Name | OXCARBAZEPINE |
| Strength Number | 60 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |